High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment
Dogra P, Šambula L, Saini J, Thangamuthu K, Athimulam S, Delivanis D, Baikousi D, Nathani R, Zhang C, Genere N, Salman Z, Turcu A, Ambroziak U, Garcia R, Achenbach S, Atkinson E, Singh S, LeBrasseur N, Kastelan D, Bancos I. High prevalence of frailty in patients with adrenal adenomas and adrenocortical hormone excess: a cross-sectional multi-centre study with prospective enrolment. European Journal Of Endocrinology 2023, 189: 318-326. PMID: 37590964, PMCID: PMC10479159, DOI: 10.1093/ejendo/lvad113.Peer-Reviewed Original ResearchConceptsPrevalence of frailtyMeasures of physical functionPhysical functionFrailty indexPerformance-based measures of physical functionTimed Up and Go testUp-and-go testCross-sectional multi-centre studyHigher prevalence of frailtyChair rise testReference subjectsAdverse health outcomesPerformance-based measuresAdrenal disordersPost-dexamethasone cortisolGait speedHealth outcomesWalk testHealth variablesFrailty prevalenceHormone excessHand gripMulti-centre studyFrailtyHighest prevalence